51Talk Online Education Group Announces Second Quarter 2025 Results
SINGAPORE, Sept. 3, 2025 /PRNewswire/ — 51Talk Online Education Group (“51Talk” or the “Company”) (NYSE American: COE), a global online... Read more.
TXSE Group Inc announces launch of Oculon Intelligence
Built with military-grade security at its core, Oculon Intelligence will provide an integrated suite of services that enables market participants to operate with... Read more.
Unstoppable Domains and 0G Foundation Announce .AGI, the Naming Standard for the Intelligent Internet
SAN FRANCISCO, Sept. 3, 2025 /PRNewswire/ — Pre sale opens today and .AGI will mint on 0G in Q1 2026 with plans to apply for an ICANN gTLD in the 2026 round.... Read more.
Midoo AI Launches the World’s First AI Language Learning Agent, Redefining How People Learn Languages
SINGAPORE, Sept. 3, 2025 /PRNewswire/ — Today, Midoo AI proudly announces the launch of the world’s first AI language learning agent, a groundbreaking... Read more.
Geekplus Announces Strong 2025 Interim Results: Revenue and Profit Soar, Adjusted EBITDA Turns Positive
HONG KONG, Sept. 3, 2025 /PRNewswire/ — Geekplus (Stock Code: 2590.HK), a global leader in intelligent robotics, has announced its unaudited interim results... Read more.
ION Commodities relaunches Softmar as volatility reshapes global freight trading
LONDON, Sept. 3, 2025 /PRNewswire/ — ION Commodities, a global leader in energy and commodity management solutions, is relaunching Softmar as a SaaS platform,... Read more.
Elsevier launches PharmaPendium AI, designed to support faster and more reliable access to regulatory insights for drug development
The solution transforms how insights are gathered from regulatory data, enabling users to quickly identify critical precedents, anticipate approval issues and avoid... Read more.
SimCorp to transform private market investing with SimCorp Alternatives
Highlights: SimCorp launches SimCorp Alternatives, a comprehensive offering designed to serve the needs of all alternative investment firms. It builds on SimCorp’s... Read more.
Bloomberg Launches Screened Choice Equity Indices for Custom Investment Strategies
NEW YORK, Sept. 3, 2025 /PRNewswire/ — Bloomberg today announced the launch of the Bloomberg Screened Choice Indices, a comprehensive and customizable suite... Read more.
Resolution Therapeutics announces first patient dosed in Phase I/II EMERALD study of RTX001 for the treatment of end-stage liver disease
RTX001 is the first engineered Regenerative Macrophage Therapy (RMT) to be evaluated in humans with advanced liver fibrosis First patient has successfully cleared... Read more.